PENTIXAPHARM HOLDING N AG (XETRA:PTP) — Stock Price
PENTIXAPHARM HOLDING N AG (XETRA:PTP) is currently trading at €1.89 EUR, down 2.33% today. Over the past 52 weeks, shares have ranged between €1.36 and €2.85. This page tracks PENTIXAPHARM HOLDING N AG's live share price on the XETRA exchange, its daily price and volume history, and — where reported — its income statement, balance sheet, cash flow statement, and earnings history. For company valuation and market capitalisation context, see PTP stock market capitalisation.
PENTIXAPHARM HOLDING N AG (PTP) Stock Price Chart — Daily History & Trading Volume
The chart below tracks PENTIXAPHARM HOLDING N AG's daily closing share price and trading volume on the XETRA exchange over the past year, giving a clear view of recent price momentum and liquidity.
PENTIXAPHARM HOLDING N AG Income Statement — Revenue, Profit & Earnings by Year
PENTIXAPHARM HOLDING N AG's annual income statement shows how revenue converts into profit each fiscal year, including gross profit, operating income, EBITDA, and net income.
| Fiscal Year |
|---|
| Total Revenue |
| Cost of Revenue |
| Gross Profit |
| Research & Development |
| SG&A |
| Total Operating Expenses |
| Operating Income |
| EBITDA |
| EBIT |
| Interest Expense |
| Income Before Tax |
| Income Tax Expense |
| Net Income |
PENTIXAPHARM HOLDING N AG Balance Sheet — Assets, Liabilities & Shareholder Equity
The balance sheet below summarizes PENTIXAPHARM HOLDING N AG's financial position at each fiscal year-end — what it owns (assets), what it owes (liabilities), and the resulting shareholder equity.
| Fiscal Year |
|---|
| Total Assets |
| Total Current Assets |
| Cash & Equivalents |
| Short-term Investments |
| Net Receivables |
| Inventory |
| Property, Plant & Equipment |
| Goodwill |
| Total Liabilities |
| Total Current Liabilities |
| Long-term Debt |
| Net Debt |
| Total Stockholder Equity |
| Retained Earnings |
PENTIXAPHARM HOLDING N AG Cash Flow Statement — Operating, Investing & Financing Activities
This cash flow statement breaks down how PENTIXAPHARM HOLDING N AG generates and spends cash across operating, investing, and financing activities each fiscal year, including free cash flow and capital expenditures.
| Fiscal Year |
|---|
| Operating Cash Flow |
| Capital Expenditures |
| Free Cash Flow |
| Investing Cash Flow |
| Financing Cash Flow |
| Dividends Paid |
| Stock-Based Compensation |
| Depreciation |
| Change in Cash |
PENTIXAPHARM HOLDING N AG Earnings History — EPS Actual vs. Analyst Estimates
Track PENTIXAPHARM HOLDING N AG's quarterly earnings per share (EPS) against Wall Street estimates, along with the earnings surprise percentage for each reporting period.
| Report Date | EPS Actual | EPS Estimate | Surprise |
|---|---|---|---|
| Sep 30, 2025 | -0.17 | — | — |
| Jun 30, 2025 | -0.18 | — | — |
| Mar 31, 2025 | -0.16 | — | — |